Aptose Biosciences Inc. (TSE:APS – Get Free Report) (NASDAQ:APTO)’s stock price hit a new 52-week low during trading on Monday . The stock traded as low as C$1.00 and last traded at C$0.97, with a volume of 3148 shares traded. The stock had previously closed at C$0.94.
Aptose Biosciences Price Performance
The company has a 50 day moving average price of C$1.29 and a 200 day moving average price of C$1.97. The firm has a market cap of C$14.68 million, a PE ratio of -0.09 and a beta of 1.47. The company has a current ratio of 0.78, a quick ratio of 5.41 and a debt-to-equity ratio of 14.27.
Aptose Biosciences (TSE:APS – Get Free Report) (NASDAQ:APTO) last announced its quarterly earnings results on Tuesday, May 14th. The biotechnology company reported C($0.98) EPS for the quarter, topping the consensus estimate of C($1.12) by C$0.14. On average, sell-side analysts expect that Aptose Biosciences Inc. will post -0.59 EPS for the current year.
Aptose Biosciences Company Profile
Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.
See Also
- Five stocks we like better than Aptose Biosciences
- Investing in large cap stocks: Diving into big caps
- Real Estate Stock Signals a Boom in Manufacturing Activity
- What Are the U.K. Market Holidays? How to Invest and Trade
- This Medical Giant’s Stock Rebounds: A 15% Upside Is the Minimum
- What is a Bond Market Holiday? How to Invest and Trade
- Financial Giant’s Shares Soar on EPS Beat and Record Asset Levels
Receive News & Ratings for Aptose Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptose Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
